We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Information for health professionals on the characteristics, diagnosis and treatment of Pontiac fever.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Employment Appeal Tribunal Judgment of Judge Tayler on 12 September 2024.
Explains how commissioners and health professionals can use data and analysis for decisions about neurology services and interventions.
The symptoms, diagnosis, management, surveillance and epidemiology of Legionnaires' disease.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Find out about the long-term effects some people can have after having COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).